Envoy Medical Inc. Class A Common Stock (COCH)

About COCH

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; an…

Sector

Health Care

Industry

Industrial Specialties

Employees

43

Website

www.envoymedical.com/

Fundamentals

1-day range

$0.6579$0.6974

Market cap

$52.34M

P/E (trailing)

—

P/E (forward)

-2.98

EPS (trailing)

$-0.86

Dividend yield

—

Beta

1.97

Avg. volume

389.6K

Forecasts

2 analyst ratings

Envoy Medical Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

• COCH

  Envoy Medical Inc. Class A Common Stock

  $0.7116

  ▼ 2.65%
  Market cap $52.34MP/E —
  $0.3625$1.89
• APT

  Alpha Pro Tech Ltd. Common Stock

  $5.43

  ▼ 0.73%
  Market cap $53.33MP/E 15.27
  $4.34$7.5
• MYO

  Myomo Inc. Common Stock

  $1.61

  ▼ 3.31%
  Market cap $50.62MP/E —
  $0.605$1.89
• MAMO

  Massimo Group Common Stock

  $1

  ▲ 0.00%
  Market cap $44.56MP/E 16.57
  $0.85$5.59
• NTRB

  Nutriband Inc. Common Stock

  $4.51

  ▼ 2.49%
  Market cap $35.43MP/E —
  $2.8$8.63
• NTIC

  Northern Technologies International Corporation Common Stock

  $8

  ▼ 0.87%
  Market cap $77.73MP/E —
  $7.25$10.03
• WBX

  Wallbox N.V. Class A Ordinary Shares

  $3.06

  ▲ 5.52%
  Market cap $82.19MP/E —
  $2.3$7.83

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• HC Wainwright & Co. Maintains Buy on Envoy Medical, Lowers Price Target to $2
  benzinga · 8/21/2026
• Ross Stores To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday
  Benzinga · 8/21/2026
• HC Wainwright & Co. Maintains Buy on Envoy Medical, Lowers Price Target to $2
  Benzinga · 8/21/2026
• Envoy Medical Expects To Submit Four Modules, Final Module Of PMA Application Targeted For Submission In Q2 2027
  Benzinga · 8/10/2026
• Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates
  Yahoo · 8/10/2026
• Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
  Yahoo · 8/10/2026
• Envoy Medical Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $51.000K Miss $80.000K Estimate
  Benzinga · 8/10/2026

• Robert Potashnick · August 24, 2026 · Grant

  250.0K
• Brent T. Lucas · June 19, 2026 · Grant

  1.00M
• Brent T. Lucas · May 29, 2026 · Grant

  32.9K @ $0.599
• McKhann Chas · April 15, 2026 · Grant

  100.0K

Institutional Ownership

March 31, 2026

Total shares held

16.99M

Total value held

$11.29M

Institutional holders

31